# NeuroPace (NPCE) — Earnings

NPCE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/npce/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.18 |
| EPS estimate | −$0.22 |
| EPS surprise | +17.39% |
| Revenue surprise | +0.94% |
| Revenue | $22.8M |
| Revenue estimate | $22.6M |
| Reported | Aug 11, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1528287/000152828726000030/npce-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/dc37df41-86c1-2c34-667d-98a460a4b02a.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 11, 2026 | −$0.22 | −$0.18 | 17.39% | $22.6M | $22.8M |
| Q1 2026 | May 12, 2026 | −$0.23 | −$0.20 | 12.97% | $21.6M | $22.0M |
| Q4 2025 | Mar 3, 2026 | −$0.16 | −$0.08 | 48.75% | $24.7M | $26.6M |
| Q3 2025 | Nov 4, 2025 | −$0.20 | −$0.11 | 43.68% | $24.6M | $27.4M |
| Q2 2025 | Aug 12, 2025 | −$0.22 | −$0.26 | -16.64% | $23.1M | $23.5M |
| Q1 2025 | May 13, 2025 | −$0.24 | −$0.21 | 12.83% | $21.9M | $22.5M |
| Q4 2024 | Mar 4, 2025 | −$0.22 | −$0.18 | 19.25% | $21.1M | $21.5M |
| Q3 2024 | Nov 12, 2024 | −$0.27 | −$0.19 | 29.26% | $19.1M | $21.1M |
| Q2 2024 | Aug 13, 2024 | −$0.30 | −$0.26 | 13.33% | $18.3M | $19.3M |
| Q1 2024 | May 8, 2024 | −$0.32 | −$0.32 | 0.40% | $17.3M | $18.1M |
| Q4 2023 | Mar 5, 2024 | −$0.32 | −$0.23 | 26.98% | $17.4M | $18.0M |
| Q3 2023 | Nov 6, 2023 | −$0.40 | −$0.28 | 30.69% | $14.2M | $16.4M |
| Q2 2023 | Aug 8, 2023 | −$0.47 | −$0.36 | 23.40% | $12.6M | $16.5M |
| Q1 2023 | May 4, 2023 | −$0.46 | −$0.41 | 10.38% | $12.2M | $14.5M |
| Q4 2022 | Mar 2, 2023 | −$0.50 | −$0.45 | 10.00% | $12.4M | $12.8M |
| Q3 2022 | Nov 8, 2022 | −$0.53 | −$0.48 | 9.00% | $9.9M | $11.2M |
| Q2 2022 | Aug 11, 2022 | −$0.45 | −$0.52 | -15.56% | $11.1M | $10.2M |
| Q1 2022 | May 12, 2022 | −$0.44 | −$0.47 | -6.21% | $10.6M | $11.4M |
| Q4 2021 | Mar 10, 2022 | −$0.33 | −$0.44 | -33.33% | $11.0M | $11.0M |
| Q3 2021 | Nov 10, 2021 | −$0.30 | −$0.34 | -11.84% | $10.8M | $10.3M |

## Frequently Asked Questions

### When did NeuroPace (NPCE) last report earnings?

NeuroPace last reported on Aug 11, 2026, covering fiscal Q2 2026.

### Did NPCE beat earnings estimates?

Yes. NeuroPace reported EPS of −$0.18 for Q2 2026 against a −$0.22 estimate — a 17.39% beat.

### How much revenue did NPCE report last quarter?

NeuroPace reported $22.8M in revenue for Q2 2026, against a consensus estimate of $22.6M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).